Lataa...
Suppressors of cytokine signaling: Potential immune checkpoint molecules for cancer immunotherapy
Inhibition of immune checkpoint molecules, PD‐1 and CTLA4, has been shown to be a promising cancer treatment. PD‐1 and CTLA4 inhibit TCR and co‐stimulatory signals. The third T cell activation signal represents the signals from the cytokine receptors. The cytokine interferon‐γ (IFNγ) plays an import...
Tallennettuna:
| Julkaisussa: | Cancer Sci |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5406529/ https://ncbi.nlm.nih.gov/pubmed/28188673 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13194 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|